AAAAAA

   
Results: 1-10 |
Results: 10
IN-VITRO HEMATOTOXICOLOGY STUDIES OF NEUTROPENIA INDUCED BY THE NOVELAGENT XK469
Authors: PARCHMENT RE TOMASZEWSKI JE GRIESHABER CK VALERIOTE FA CORBETT TH LORUSSO PM
Citation: Re. Parchment et al., IN-VITRO HEMATOTOXICOLOGY STUDIES OF NEUTROPENIA INDUCED BY THE NOVELAGENT XK469, Annals of oncology, 9, 1998, pp. 205-205
PHASE-I CLINICAL-TRIAL OF KRN5500
Authors: LORUSSO PM FOSTER B WOZNIAK A FLAHERTY L SHIELDS A ZALUPSKI M KOCAREK T GRIESHABER CK PARCHMENT RE
Citation: Pm. Lorusso et al., PHASE-I CLINICAL-TRIAL OF KRN5500, Annals of oncology, 9, 1998, pp. 474-474
PHARMACOKINETIC STUDIES IN MICE OF 2 NEW THIOXANTHENONES (183577 AND 232759) THAT SHOWED PREFERENTIAL SOLID TUMOR-ACTIVITY
Authors: FOSTER BJ WIEGAND RA PUGH S LORUSSO PM RAKE J CORBETT TH
Citation: Bj. Foster et al., PHARMACOKINETIC STUDIES IN MICE OF 2 NEW THIOXANTHENONES (183577 AND 232759) THAT SHOWED PREFERENTIAL SOLID TUMOR-ACTIVITY, Clinical cancer research, 3(11), 1997, pp. 2047-2053
PRECLINICAL PHARMACOKINETIC, ANTITUMOR AND TOXICITY STUDIES WITH CL-994 (N-ACETYLDINALINE)
Authors: FOSTER BJ JONES L WIEGAND R LORUSSO PM CORBETT TH
Citation: Bj. Foster et al., PRECLINICAL PHARMACOKINETIC, ANTITUMOR AND TOXICITY STUDIES WITH CL-994 (N-ACETYLDINALINE), Investigational new drugs, 15(3), 1997, pp. 187-194
PRECLINICAL ANTITUMOR-ACTIVITY OF CI-994
Authors: LORUSSO PM DEMCHIK L FOSTER B KNIGHT J BISSERY MC POLIN LM LEOPOLD WR CORBETT TH
Citation: Pm. Lorusso et al., PRECLINICAL ANTITUMOR-ACTIVITY OF CI-994, Investigational new drugs, 14(4), 1996, pp. 349-356
LEVELS OF 5-HYDROXYMETHYL-2'-DEOXYURIDINE IN DNA FROM BLOOD AS A MARKER OF BREAST-CANCER
Authors: DJURIC Z HEILBRUN LK SIMON MS SMITH D LUONGO DA LORUSSO PM MARTINO S
Citation: Z. Djuric et al., LEVELS OF 5-HYDROXYMETHYL-2'-DEOXYURIDINE IN DNA FROM BLOOD AS A MARKER OF BREAST-CANCER, Cancer, 77(4), 1996, pp. 691-696
PHARMACOKINETICS OF 9-METHOXY-N, N-DIMETHYL-5-NITROPYRAZOLO [3,4,5-KL]ACRIDINE-2(6H)-PROPANAMINE (PZA, PD-115934, NSC-366140) IN MICE - GUIDELINES FOR EARLY CLINICAL-TRIALS
Authors: FOSTER BJ WIEGAND RA LORUSSO PM BAKER LH
Citation: Bj. Foster et al., PHARMACOKINETICS OF 9-METHOXY-N, N-DIMETHYL-5-NITROPYRAZOLO [3,4,5-KL]ACRIDINE-2(6H)-PROPANAMINE (PZA, PD-115934, NSC-366140) IN MICE - GUIDELINES FOR EARLY CLINICAL-TRIALS, Clinical cancer research, 1(8), 1995, pp. 831-837
PHASE-I STUDY OF MONOCLONAL-ANTIBODY RICIN-A CHAIN IMMUNOCONJUGATE XOMAZYME-791 IN PATIENTS WITH METASTATIC COLON-CANCER
Authors: LORUSSO PM LOMEN PL REDMAN BG POPLIN E BANDER JJ VALDIVIESO M
Citation: Pm. Lorusso et al., PHASE-I STUDY OF MONOCLONAL-ANTIBODY RICIN-A CHAIN IMMUNOCONJUGATE XOMAZYME-791 IN PATIENTS WITH METASTATIC COLON-CANCER, American journal of clinical oncology, 18(4), 1995, pp. 307-312
PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS
Authors: FOSTER BJ LORUSSO PM POPLIN E ZALUPSKI M VALDIVIESO M WOZNIAK A FLAHERTY L KASUNIC DA EARHART RH BAKER LH
Citation: Bj. Foster et al., PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS, Investigational new drugs, 13(4), 1995, pp. 321-326
IN-VIVO-IN-VITRO CORRELATION OF MYELOTOXICITY OF 9-METHOXYPYRAZOLOACRIDINE (NSC-366140, PD115934) TO MYELOID AND ERYTHROID HEMATOPOIETIC PROGENITORS FROM HUMAN, MURINE, AND CANINE MARROW
Authors: PARCHMENT RE VOLPE DA LORUSSO PM ERICKSONMILLER CL MURPHY MJ GRIESHABER CK
Citation: Re. Parchment et al., IN-VIVO-IN-VITRO CORRELATION OF MYELOTOXICITY OF 9-METHOXYPYRAZOLOACRIDINE (NSC-366140, PD115934) TO MYELOID AND ERYTHROID HEMATOPOIETIC PROGENITORS FROM HUMAN, MURINE, AND CANINE MARROW, Journal of the National Cancer Institute, 86(4), 1994, pp. 273-280
Risultati: 1-10 |